FGF2 and prostate cancer: Furthermore, we confirmed that FGF2 expression in HUVEC and prostate cancer cells in the co-culture system did not rise following the indicated docetaxel treatment, which indicated that the crosstalk between prostate cancer cells and HUVEC cells was the major factor that determined the secretion of FGF2.